Peringatan Keamanan

The toxicity of phenserine, a derivate of physostigmine, is dramatically less. Doses of 20 mg/kg (rats, intravenous) of phenserine have not been associated with toxicity or deaths.

Phenserine

DB04892

small molecule investigational

Deskripsi

Phenserine is under development by Axonyx, a US biopharmaceutical company that focuses on treatments for dementia. Phenserine is a next generation acetylcholinesterase (AChE) inhibitor indicated for the treatment of AD. Unlike currently marketed AChE inhibitors, it has a dual mechanism of action that also includes anti-amyloid activity, which may confer disease-modifying effects in patients with AD. If this is substantiated in an ongoing clinical trial then phenserine may open the door to an entirely new type of treatment for AD. Axonyx announced on 20 September 2005 that phenserine was ineffective in two curtailed phase 3 trials.

Struktur Molekul 2D

Berat 337.4155
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) 8 to 10 hours
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Rapidly absorbed and cleared from the body.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

292 Data
Dipyridamole The therapeutic efficacy of Phenserine can be decreased when used in combination with Dipyridamole.
Ephedrine Phenserine may increase the neuromuscular blocking activities of Ephedrine.
Bambuterol Phenserine may increase the neuromuscular blocking activities of Bambuterol.
Clevidipine Phenserine may increase the neuromuscular blocking activities of Clevidipine.
Sar9, Met (O2)11-Substance P Phenserine may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P.
Mirabegron Phenserine may increase the neuromuscular blocking activities of Mirabegron.
Moxisylyte Phenserine may increase the neuromuscular blocking activities of Moxisylyte.
Propacetamol Phenserine may increase the neuromuscular blocking activities of Propacetamol.
Procaine Phenserine may increase the neuromuscular blocking activities of Procaine.
Cocaine Phenserine may increase the neuromuscular blocking activities of Cocaine.
Trimethaphan Phenserine may increase the neuromuscular blocking activities of Trimethaphan.
Doxacurium Phenserine may increase the neuromuscular blocking activities of Doxacurium.
Chloroprocaine Phenserine may increase the neuromuscular blocking activities of Chloroprocaine.
Tubocurarine Phenserine may increase the neuromuscular blocking activities of Tubocurarine.
Aclidinium Phenserine may increase the neuromuscular blocking activities of Aclidinium.
Butyrylthiocholine Phenserine may increase the neuromuscular blocking activities of Butyrylthiocholine.
Oxybuprocaine Phenserine may increase the neuromuscular blocking activities of Oxybuprocaine.
Benzonatate Phenserine may increase the neuromuscular blocking activities of Benzonatate.
Succinylcholine The metabolism of Succinylcholine can be decreased when combined with Phenserine.
Tramadol The therapeutic efficacy of Tramadol can be decreased when used in combination with Phenserine.
Trospium The therapeutic efficacy of Trospium can be decreased when used in combination with Phenserine.
Oxyphenonium The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Phenserine.
Butabarbital The therapeutic efficacy of Butabarbital can be decreased when used in combination with Phenserine.
Butalbital The therapeutic efficacy of Butalbital can be decreased when used in combination with Phenserine.
Benzatropine The therapeutic efficacy of Benzatropine can be decreased when used in combination with Phenserine.
Ziprasidone The therapeutic efficacy of Ziprasidone can be decreased when used in combination with Phenserine.
Disopyramide The therapeutic efficacy of Disopyramide can be decreased when used in combination with Phenserine.
Talbutal The therapeutic efficacy of Talbutal can be decreased when used in combination with Phenserine.
Pentobarbital The therapeutic efficacy of Pentobarbital can be decreased when used in combination with Phenserine.
Amitriptyline The therapeutic efficacy of Amitriptyline can be decreased when used in combination with Phenserine.
Ipratropium The therapeutic efficacy of Ipratropium can be decreased when used in combination with Phenserine.
Methadone The therapeutic efficacy of Methadone can be decreased when used in combination with Phenserine.
Olanzapine The therapeutic efficacy of Olanzapine can be decreased when used in combination with Phenserine.
Metixene The therapeutic efficacy of Metixene can be decreased when used in combination with Phenserine.
Terfenadine The therapeutic efficacy of Terfenadine can be decreased when used in combination with Phenserine.
Buclizine The therapeutic efficacy of Buclizine can be decreased when used in combination with Phenserine.
Clozapine The therapeutic efficacy of Clozapine can be decreased when used in combination with Phenserine.
Doxylamine The therapeutic efficacy of Doxylamine can be decreased when used in combination with Phenserine.
Trihexyphenidyl The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Phenserine.
Oxyphencyclimine The therapeutic efficacy of Oxyphencyclimine can be decreased when used in combination with Phenserine.
Procyclidine The therapeutic efficacy of Procyclidine can be decreased when used in combination with Phenserine.
Profenamine The therapeutic efficacy of Profenamine can be decreased when used in combination with Phenserine.
Secobarbital The therapeutic efficacy of Secobarbital can be decreased when used in combination with Phenserine.
Promazine The therapeutic efficacy of Promazine can be decreased when used in combination with Phenserine.
Hyoscyamine The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Phenserine.
Cyproheptadine The therapeutic efficacy of Cyproheptadine can be decreased when used in combination with Phenserine.
Imipramine The therapeutic efficacy of Imipramine can be decreased when used in combination with Phenserine.
Methscopolamine bromide The therapeutic efficacy of Methscopolamine bromide can be decreased when used in combination with Phenserine.
Metharbital The therapeutic efficacy of Metharbital can be decreased when used in combination with Phenserine.
Fluoxetine The therapeutic efficacy of Fluoxetine can be decreased when used in combination with Phenserine.
Chlorpromazine The therapeutic efficacy of Chlorpromazine can be decreased when used in combination with Phenserine.
Darifenacin The therapeutic efficacy of Darifenacin can be decreased when used in combination with Phenserine.
Tridihexethyl The therapeutic efficacy of Tridihexethyl can be decreased when used in combination with Phenserine.
Triflupromazine The therapeutic efficacy of Triflupromazine can be decreased when used in combination with Phenserine.
Dextromethorphan The therapeutic efficacy of Dextromethorphan can be decreased when used in combination with Phenserine.
Anisotropine methylbromide The therapeutic efficacy of Anisotropine methylbromide can be decreased when used in combination with Phenserine.
Nortriptyline The therapeutic efficacy of Nortriptyline can be decreased when used in combination with Phenserine.
Amoxapine The therapeutic efficacy of Amoxapine can be decreased when used in combination with Phenserine.
Atropine The therapeutic efficacy of Atropine can be decreased when used in combination with Phenserine.
Thiopental The therapeutic efficacy of Thiopental can be decreased when used in combination with Phenserine.
Nicardipine The therapeutic efficacy of Nicardipine can be decreased when used in combination with Phenserine.
Mecamylamine The therapeutic efficacy of Mecamylamine can be decreased when used in combination with Phenserine.
Pirenzepine The therapeutic efficacy of Pirenzepine can be decreased when used in combination with Phenserine.
Paroxetine The therapeutic efficacy of Paroxetine can be decreased when used in combination with Phenserine.
Homatropine methylbromide The therapeutic efficacy of Homatropine methylbromide can be decreased when used in combination with Phenserine.
Scopolamine The therapeutic efficacy of Scopolamine can be decreased when used in combination with Phenserine.
Isoflurane The therapeutic efficacy of Isoflurane can be decreased when used in combination with Phenserine.
Benzquinamide The therapeutic efficacy of Benzquinamide can be decreased when used in combination with Phenserine.
Clidinium The therapeutic efficacy of Clidinium can be decreased when used in combination with Phenserine.
Propiomazine The therapeutic efficacy of Propiomazine can be decreased when used in combination with Phenserine.
Propantheline The therapeutic efficacy of Propantheline can be decreased when used in combination with Phenserine.
Primidone The therapeutic efficacy of Primidone can be decreased when used in combination with Phenserine.
Dicyclomine The therapeutic efficacy of Dicyclomine can be decreased when used in combination with Phenserine.
Biperiden The therapeutic efficacy of Biperiden can be decreased when used in combination with Phenserine.
Brompheniramine The therapeutic efficacy of Brompheniramine can be decreased when used in combination with Phenserine.
Methylphenobarbital The therapeutic efficacy of Methylphenobarbital can be decreased when used in combination with Phenserine.
Quinidine The therapeutic efficacy of Quinidine can be decreased when used in combination with Phenserine.
Amantadine The therapeutic efficacy of Amantadine can be decreased when used in combination with Phenserine.
Maprotiline The therapeutic efficacy of Maprotiline can be decreased when used in combination with Phenserine.
Methantheline The therapeutic efficacy of Methantheline can be decreased when used in combination with Phenserine.
Hexafluronium The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Phenserine.
Cycrimine The therapeutic efficacy of Cycrimine can be decreased when used in combination with Phenserine.
Desloratadine The therapeutic efficacy of Desloratadine can be decreased when used in combination with Phenserine.
Glycopyrronium The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Phenserine.
Tolterodine The therapeutic efficacy of Tolterodine can be decreased when used in combination with Phenserine.
Oxybutynin The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Phenserine.
Promethazine The therapeutic efficacy of Promethazine can be decreased when used in combination with Phenserine.
Diphenhydramine The therapeutic efficacy of Diphenhydramine can be decreased when used in combination with Phenserine.
Pentolinium The therapeutic efficacy of Pentolinium can be decreased when used in combination with Phenserine.
Doxepin The therapeutic efficacy of Doxepin can be decreased when used in combination with Phenserine.
Flavoxate The therapeutic efficacy of Flavoxate can be decreased when used in combination with Phenserine.
Desipramine The therapeutic efficacy of Desipramine can be decreased when used in combination with Phenserine.
Orphenadrine The therapeutic efficacy of Orphenadrine can be decreased when used in combination with Phenserine.
Phenobarbital The therapeutic efficacy of Phenobarbital can be decreased when used in combination with Phenserine.
Escitalopram The therapeutic efficacy of Escitalopram can be decreased when used in combination with Phenserine.
Quetiapine The therapeutic efficacy of Quetiapine can be decreased when used in combination with Phenserine.
Levacetylmethadol The therapeutic efficacy of Levacetylmethadol can be decreased when used in combination with Phenserine.
Diphenidol The therapeutic efficacy of Diphenidol can be decreased when used in combination with Phenserine.
Aripiprazole The therapeutic efficacy of Aripiprazole can be decreased when used in combination with Phenserine.
Chlorprothixene The therapeutic efficacy of Chlorprothixene can be decreased when used in combination with Phenserine.

Target Protein

Acetylcholinesterase ACHE
Cholinesterase BCHE
Amyloid-beta precursor protein APP

Referensi & Sumber

Artikel (PubMed)
  • PMID: 16248851
    Greig NH, Ruckle J, Comer P, Brownell L, Holloway HW, Flanagan DR Jr, Canfield CJ, Burford RG: Anticholinesterase and pharmacokinetic profile of phenserine in healthy elderly human subjects. Curr Alzheimer Res. 2005 Oct;2(4):483-92.
  • PMID: 17594192
    Klein J: Phenserine. Expert Opin Investig Drugs. 2007 Jul;16(7):1087-97.
  • PMID: 16049844
    Thatte U: Phenserine (Axonyx/NIH). IDrugs. 2000 Oct;3(10):1222-8.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul